Systemic combination treatment for psoriasis: A review

Acta Dermato-Venereologica

Volumn 90, Issue 4, 2010, Pages 341-349

  Jensen, Peter ^a   Skov, Lone ^a   Zachariae, Claus ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Combination treatment; Psoriasis; Systemic treatment

Indexed keywords

ALEFACEPT; BETAMETHASONE; CALCITRIOL; CHLORPHENIRAMINE; CHOLESTEROL; CIMETIDINE; CYCLOSPORIN; ETANERCEPT; ETRETIN; ETRETINATE; ICOSAPENTAENOIC ACID; METHOTREXATE; PIOGLITAZONE; PSORALEN; RETINOID; TRIACYLGLYCEROL; BIOLOGICAL PRODUCT; DERMATOLOGICAL AGENT; PHOTOSENSITIZING AGENT;

BIOLOGICAL THERAPY; CANCER RISK; CHOLESTEROL BLOOD LEVEL; COCHRANE LIBRARY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; HUMAN; INFORMATION RETRIEVAL; MEDLINE; MONOTHERAPY; NARROW BAND IMAGING; PHOTOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIASIS; PSORIASIS SEVERITY INDEX; PSORIATIC ARTHRITIS; PUVA; RADIATION EXPOSURE; REMISSION; RETROSPECTIVE STUDY; REVIEW; RHEUMATOID ARTHRITIS; SKIN CANCER; SYSTEMATIC REVIEW; SYSTEMIC COMBINATION TREATMENT; SYSTEMIC THERAPY; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; ULTRAVIOLET B RADIATION; DRUG COMBINATION; EVIDENCE BASED MEDICINE; PHOTOCHEMOTHERAPY;

BIOLOGICAL PRODUCTS; CYCLOSPORINE; DERMATOLOGIC AGENTS; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; HUMANS; METHOTREXATE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PSORIASIS; RETINOIDS; TREATMENT OUTCOME;

EID: 77954932166     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0905     Document Type: Review

References (105)

1. Lebwohl M. Psoriasis. Lancet 2003; 361: 1197-1204.
2. Raychaudhuri SP, Farber EM. The prevalence of psoriasis in the world. J Eur Acad Dermatol Venereol 2001; 15: 16-17.
3. Fraser AD, van Kuijk AW, Westhovens R, Karim Z, Wakefield R, Gerards AH, et al. A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis. Ann Rheum Dis 2005; 64: 859-864.
4. Mazzanti G, Coloni L, De SG, Paladini G. Methotrexate and cyclosporin combined therapy in severe psoriatic arthritis. A pilot study. Acta Derm Venereol Suppl 1994; 186: 116-117.
5. Aydin F, Canturk T, Senturk N, Turanli AY. Methotrexate and ciclosporin combination for the treatment of severe psoriasis. Clin Exp Dermatol 2006; 31: 520-524. (Pubitemid 43806583)
6. Clark CM, Kirby B, Morris AD, Davison S, Zaki I, Emerson R, et al. Combination treatment with methotrexate and cyclosporin for severe recalcitrant psoriasis. Br J Dermatol 1999; 141: 279-282. (Pubitemid 29397996)
7. Korstanje MJ, van Breda Vriesman CJ, van de Staak WJ. Cyclosporine and methotrexate: a dangerous combination. J Am Acad Dermatol 1990; 23: 320-321.
8. Wong KC, Georgouras K. Low dose cyclosporin A and methotrexate in the treatment of psoriasis. Acta Derm Venereol 1999; 79: 87. (Pubitemid 29079342)
9. Proudman SM, Conaghan PG, Richardson C, Griffiths B, Green MJ, McGonagle D, et al. Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone. Arthritis Rheum 2000; 43: 1809-1819.
10. Bejarano V, Conaghan PG, Proudman SM, Buch MH, Brown AK, Emery P. Long-term efficacy and toxicity of ciclosporin A in combination with methotrexate in poor prognosis rheumatoid arthritis. Ann Rheum Dis 2009; 68: 761-763.
11. Asawanonda P, Nateetongrungsak Y. Methotrexate plus narrowband UVB phototherapy versus narrowband UVB phototherapy alone in the treatment of plaque-type psoriasis: a randomized, placebo-controlled study. J Am Acad Dermatol 2006; 54: 1013-1018.
12. Shehzad T, Dar NR, Zakria M. Efficacy of concomitant use of PUVA and methotrexate in disease clearance time in plaque type psoriasis. J Pak Med Assoc 2004; 54: 453-455. (Pubitemid 39388207)
13. Morison WL, Momtaz K, Parrish JA, Fitzpatrick TB. Combined methotrexate-PUVA therapy in the treatment of psoriasis. J Am Acad Dermatol 1982; 6: 46-51. (Pubitemid 12197905)
14. Paul BS, Momtaz K, Stern RS, Arndt KA, Parrish JA. Combined methotrexate - ultraviolet B therapy in the treatment of psoriasis. J Am Acad Dermatol 1982; 7: 758-762.
15. Laxmisha C, Vinod KP, Thappa DM. Modified combined methotrexate PUVA therapy in the treatment of recalcitrant psoriasis: a preliminary report. Indian J Dermatol Venereol Leprol 2006; 72: 153-155. (Pubitemid 43786960)
16. Tuyp E, MacKie RM. Combination therapy for psoriasis with methotrexate and etretinate. J Am Acad Dermatol 1986; 14: 70-73. (Pubitemid 16137930)
17. Lowenthal KE, Horn PJ, Kalb RE. Concurrent use of methotrexate and acitretin revisited. J Dermatolog Treat 2008; 19: 22-26.
18. Zachariae H. Methotrexate and etretinate as concurrent therapies in the treatment of psoriasis. Arch Dermatol 1984; 120: 155.
19. Vanderveen EE, Ellis CN, Campbell JP, Case PC, Voorhees JJ. Methotrexate and etretinate as concurrent therapies in severe psoriasis. Arch Dermatol 1982; 118: 660-662.
20. Adams JD. Concurrent methotrexate and etretinate therapy for psoriasis. Arch Dermatol 1983; 119: 793.
21. Conley J, Nanton J, Dhawan S, Pearce DJ, Feldman SR. Novel combination regimens: biologics and acitretin for the treatment of psoriasis - a case series. J Dermatolog Treat 2006; 17: 86-89.
22. Rosenbaum MM, Roenigk HH, Jr. Treatment of generalized pustular psoriasis with etretinate (Ro 10-9359) and methotrexate. J Am Acad Dermatol 1984; 10: 357-361. (Pubitemid 14181965)
23. Gupta R, Gupta S. Methotrexate-betamethasone weekly oral pulse in psoriasis. J Dermatolog Treat 2007; 18: 291-294. (Pubitemid 47537261)
24. Özdemir M, Engin B, Baysal I, Mevlitoglu I. A randomized comparison of acitretin-narrow-band TL-01 phototherapy and acitretin-psoralen plus ultraviolet A for psoriasis. Acta Derm Venereol 2008; 88: 589-593.
25. Lauharanta J, Juvakoski T, Lassus A. A clinical evaluation of the effects of an aromatic retinoid (Tigason), combination of retinoid and PUVA, and PUVA alone in severe psoriasis. Br J Dermatol 1981; 104: 325-332. (Pubitemid 11060745)
26. Lauharanta J, Geiger JM. A double-blind comparison of acitretin and etretinate in combination with bath PUVA in the treatment of extensive psoriasis. Br J Dermatol 1989; 121: 107-112. (Pubitemid 19177127)
27. Parker S, Coburn P, Lawrence C, Marks J, Shuster S. A randomized double-blind comparison of PUVA-etretinate and PUVA-placebo in the treatment of chronic plaque psoriasis. Br J Dermatol 1984; 110: 215-220. (Pubitemid 14184213)
28. Tanew A, Guggenbichler A, Honigsmann H, Geiger JM, Fritsch P. Photochemotherapy for severe psoriasis without or in combination with acitretin: a randomized, double-blind comparison study. J Am Acad Dermatol 1991; 25: 682-684.
29. Saurat JH, Geiger JM, Amblard P, Beani JC, Boulanger A, Claudy A, et al. Randomized double-blind multicenter study comparing acitretin-PUVA, etretinate-PUVA and placebo-PUVA in the treatment of severe psoriasis. Dermatologica 1988; 177: 218-224.
30. Ruzicka T, Sommerburg C, Braun-Falco O, Koster W, Lengen W, Lensing W, et al. Efficiency of acitretin in combination with UV-B in the treatment of severe psoriasis. Arch Dermatol 1990; 126: 482-486. (Pubitemid 20128961)
31. Lowe NJ, Prystowsky JH, Bourget T, Edelstein J, Nychay S, Armstrong R. Acitretin plus UVB therapy for psoriasis. Comparisons with placebo plus UVB and acitretin alone. J Am Acad Dermatol 1991; 24: 591-594.
32. Lebwohl M, Menter A, Koo J, Feldman S. Case studies in severe psoriasis: a clinical strategy. J Dermatolog Treat 2003; 14 Suppl 2: 26-46. (Pubitemid 37474604)
33. Lane-Brown M. 5-Methoxy psoralen, etretinate, and UVA for psoriasis. Int J Dermatol 1987; 26: 655-659. (Pubitemid 18005435)
34. Takashima A, Sunohara A, Matsunami E, Mizuno N. Comparison of therapeutic efficacy of topical PUVA, oral etretinate, and combined PUVA and etretinate for the treatment of psoriasis and development of PUVA lentigines and antinuclear antibodies. J Dermatol 1988; 15: 473-479. (Pubitemid 19062789)
35. Fritsch PO, Honigsmann H, Jaschke E, Wolff K. Augmentation of oral methoxsalen-photochemotherapy with an oral retinoic acid derivative. J Invest Dermatol 1978; 70: 178-182. (Pubitemid 8400719)
36. Orfanos CE, Steigleder GK, Pullmann H, Bloch PH. Oral retinoid and UVB radiation: a new, alternative treatment for psoriasis on an out-patient basis. Acta Derm Venereol 1979; 59: 241-244. (Pubitemid 9172864)
37. Iest J, Boer J. Combined treatment of psoriasis with acitretin and UVB phototherapy compared with acitretin alone and UVB alone. Br J Dermatol 1989; 120: 665-670. (Pubitemid 19143300)
38. Heidbreder G, Christophers E. Therapy of psoriasis with retinoid plus PUVA: clinical and histologic data. Arch Dermatol Res 1979; 264: 331-337. (Pubitemid 9201613)
39. Vaatainen N, Hollmen A, Fraki JE. Trimethylpsoralen bath plus ultraviolet A combined with oral retinoid (etretinate) in the treatment of severe psoriasis. J Am Acad Dermatol 1985; 12: 52-55. (Pubitemid 15188844)
40. Thirumoorthy T, Tham SN, Tan YC. Combination therapy of oral methoxypsoralen: photochemotherapy (PUVA) and an aromatic retinoid (etretinate, tigason) in the treatment of psoriasis. J Dermatol 1986; 13: 132-136. (Pubitemid 16022572)
41. Yelverton CB, Yentzer BA, Clark A, Pearce DJ, Balkrishnan R, Camacho FT, et al. Home narrowband UV-B phototherapy in combination with low-dose acitretin in patients with moderate to severe psoriasis. Arch Dermatol 2008; 144: 1224-1225.
42. Petzelbauer P, Honigsmann H, Langer K, Anegg B, Strohal R, Tanew A, et al. Cyclosporin A in combination with photochemotherapy (PUVA) in the treatment of psoriasis. Br J Dermatol 1990; 123: 641-647. (Pubitemid 20377655)
43. Green C, Lakshmipathi T, Johnson BE, Ferguson J. A comparison of the efficacy and relapse rates of narrowband UVB (TL-01) monotherapy vs. etretinate (re-TL-01) vs. etretinate-PUVA (re-PUVA) in the treatment of psoriasis patients. Br J Dermatol 1992; 127: 5-9.
44. Muchenberger S, Schopf E, Simon JC. The combination of oral acitretin and bath PUVA for the treatment of severe psoriasis. Br J Dermatol 1997; 137: 587-589. (Pubitemid 27469511)
45. Grupper C, Berretti B. Treatment of psoriasis by oral PUVA therapy combined with aromatic retinoid (Ro 10-9359; Tigason). Dermatologica 1981; 162: 404-413. (Pubitemid 11117755)
46. Spuls PI, Rozenblit M, Lebwohl M. Retrospective study of the efficacy of narrowband UVB and acitretin. J Dermatolog Treat 2003; 14 Suppl 2: 17-20. (Pubitemid 37474602)
47. Kampitak T, Asawanonda P. The efficacy of combination treatment with narrowband UVB (TL-01) and acitretin vs narrowband UVB alone in plaque-type psoriasis: a retrospective study. J Med Assoc Thai 2006; 89 Suppl 3: S20-S24.
48. Shiri J, Amichai B, Grunwald MH. Re-climatotherapy: a combination of acitretin and climatotherapy at the Dead Sea. J Am Acad Dermatol 2005; 52: 541-542.
49. Carlin CS, Callis KP, Krueger GG. Efficacy of acitretin and commercial tanning bed therapy for psoriasis. Arch Dermatol 2003; 139: 436-442.
50. Ezquerra GM, Regana MS, Millet PU. Combination of acitretin and oral calcitriol for treatment of plaque-type psoriasis. Acta Derm Venereol 2007; 87: 449-450. (Pubitemid 351373434)
51. Mittal R, Malhotra S, Pandhi P, Kaur I, Dogra S. Efficacy and safety of combination acitretin and pioglitazone therapy in patients with moderate to severe chronic plaque-type psoriasis: a randomized, double-blind, placebo-controlled clinical trial. Arch Dermatol 2009; 145: 387-393.
52. Danno K, Sugie N. Combination therapy with low-dose etretinate and eicosapentaenoic acid for psoriasis vulgaris. J Dermatol 1998; 25: 703-705. (Pubitemid 28566705)
53. Korstanje MJ, Hulsmans RF. Combination therapy cyclosporin A - PUVA in psoriasis. Acta Derm Venereol 1990; 70: 89-90.
54. Marcil I, Stern RS. Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study. Lancet 2001; 358: 1042-1045. (Pubitemid 32925124)
55. Korstanje MJ, van de Staak WJ. Combination-therapy cyclosporin-A - etretinate for psoriasis. Clin Exp Dermatol 1990; 15: 172-173.
56. Kokelj F, Plozzer C, Torsello P, Trevisan G. Efficacy of cyclosporine plus etretinate in the treatment of erythrodermic psoriasis (three case reports). J Eur Acad Dermatol Venereol 1998; 11: 177-179. (Pubitemid 28445044)
57. Korstanje MJ, Bessems PJ, van de Staak WJ. Combination therapy ciclosporin-etretinate effective in erythrodermic psoriasis. Dermatologica 1989; 179: 94.
58. Brechtel B, Wellenreuther U, Toppe E, Czarnetzki BM. Combination of etretinate with cyclosporine in the treatment of severe recalcitrant psoriasis. J Am Acad Dermatol 1994; 30: 1023-1024. (Pubitemid 24166578)
59. Kuijpers AL, van Dooren-Greebe JV, van de Kerkhof PC. Failure of combination therapy with acitretin and cyclosporin A in 3 patients with erythrodermic psoriasis. Dermatology 1997; 194: 88-90.
60. Ameen M, Smith HR, Barker JN. Combined mycophenolate mofetil and cyclosporin therapy for severe recalcitrant psoriasis. Clin Exp Dermatol 2001; 26: 480-483. (Pubitemid 32955454)
61. Kirby B, Harrison PV. Combination low-dose cyclosporin (Neoral) and hydroxyurea for severe recalcitrant psoriasis. Br J Dermatol 1999; 140: 186-187. (Pubitemid 29074567)
62. Zachariae C, Mork NJ, Reunala T, Lorentzen H, Falk E, Karvonen SL, et al. The combination of etanercept and methotrexate increases the effectiveness of treatment in active psoriasis despite inadequate effect of methotrexate therapy. Acta Derm Venereol 2008; 88: 495-501.
63. Mease PJ, Gladman DD, Keystone EC. Alefacept in combination with methotrexate for the treatment of psoriatic arthritis: results of a randomized, double-blind, placebo-controlled study. Arthritis Rheum 2006; 54: 1638-1645.
64. Driessen RJ, van de Kerkhof PC, de Jong EM. Etanercept combined with methotrexate for high-need psoriasis. Br J Dermatol 2008; 159: 460-463.
65. Yamauchi PS, Lowe NJ. Etanercept therapy allows the tapering of methotrexate and sustained clinical responses in patients with moderate to severe psoriasis. Int J Dermatol 2008; 47: 202-204.
66. Strober BE. Successful treatment of psoriasis and psoriatic arthritis with etanercept and methotrexate in a patient newly unresponsive to infliximab. Arch Dermatol 2004; 140: 366.
67. Iyer S, Yamauchi P, Lowe NJ. Etanercept for severe psoriasis and psoriatic arthritis: observations on combination therapy. Br J Dermatol 2002; 146: 118-121. (Pubitemid 34158419)
68. Strober BE, Clarke S. Etanercept for the treatment of psoriasis: combination therapy with other modalities. J Drugs Dermatol 2004; 3: 270-272.
69. Langewouters AM, Van Erp PE, de Jong EM, van de Kerkhof PC. The added therapeutic efficacy and safety of alefacept in combination with other (systemic) anti-psoriatics in refractory psoriasis. J Dermatolog Treat 2006; 17: 362-369.
70. Krueger GG, Gottlieb AB, Sterry W, Korman N, van de Kerkhof P. A multicenter, open-label study of repeat courses of intramuscular alefacept in combination with other psoriasis therapies in patients with chronic plaque psoriasis. J Dermatolog Treat 2008; 19: 146-155. (Pubitemid 351882998)
71. Kirby B, Marsland AM, Carmichael AJ, Griffiths CE. Successful treatment of severe recalcitrant psoriasis with combination infliximab and methotrexate. Clin Exp Dermatol 2001; 26: 27-29. (Pubitemid 32204840)
72. Heikkila H, Ranki A, Cajanus S, Karvonen SL. Infliximab combined with methotrexate as long-term treatment for erythrodermic psoriasis. Arch Dermatol 2005; 141: 1607-1610. (Pubitemid 41815864)
73. Takahashi MD, Castro LG, Romiti R. Infliximab, as sole or combined therapy, induces rapid clearing of erythrodermic psoriasis. Br J Dermatol 2007; 157: 828-831. (Pubitemid 47389895)
74. Warren RB, Brown BC, Carmichael AJ, Griffiths CE. Long-term control of recalcitrant psoriasis with combination infliximab and methotrexate. Clin Exp Dermatol 2009; 34: 415-416.
75. Barland C, Kerdel FA. Addition of low-dose methotrexate to infliximab in the treatment of a patient with severe, recalcitrant pustular psoriasis. Arch Dermatol 2003; 139: 949-950. (Pubitemid 36898946)
76. Dalaker M, Bonesronning JH. Long-term maintenance treatment of moderate-to-severe plaque psoriasis with infliximab in combination with methotrexate or azathioprine in a retrospective cohort. J Eur Acad Dermatol Venereol 2009; 23: 277-282.
77. Gisondi P, Del Giglio M, Cotena C, Girolomoni G. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial. Br J Dermatol 2008; 158: 1345-1349. (Pubitemid 351692891)
78. Adisen E, Karaca F, Gurer MA. When there is no single best biological agent: psoriasis and psoriatic arthritis in the same patient responding to two different biological agents. Clin Exp Dermatol 2008; 33: 164-166. (Pubitemid 351197223)
79. Smith EC, Riddle C, Menter MA, Lebwohl M. Combining systemic retinoids with biologic agents for moderate to severe psoriasis. Int J Dermatol 2008; 47: 514-518. (Pubitemid 351560322)
80. Gisondi P, Girolomoni G. Combination of efalizumab and acitretin in chronic plaque psoriasis. J Eur Acad Dermatol Venereol 2008; 22: 247-248.
81. Jacobe H, Winterfield L, Kim F, Huet-Adams B, Cayce R. The role of narrowband UV-B plus alefacept combination therapy in the treatment of psoriasis. Arch Dermatol 2008; 144: 1067-1068.
82. Legat FJ, Hofer A, Wackernagel A, Salmhofer W, Quehenberger F, Kerl H, et al. Narrowband UV-B phototherapy, alefacept, and clearance of psoriasis. Arch Dermatol 2007; 143: 1016-1022.
83. Ortonne JP, Khemis A, Koo JY, Choi J. An open-label study of alefacept plus ultraviolet B light as combination therapy for chronic plaque psoriasis. J Eur Acad Dermatol Venereol 2005; 19: 556-563. (Pubitemid 41742835)
84. Scheinfeld N. Therapy-resistant psoriasis treated with alefacept and subsequent narrow band ultraviolet B phototherapy with total clearing of psoriasis. Dermatol Online J 2005; 11: 7. (Pubitemid 41215330)
85. Kircik L, Bagel J, Korman N, Menter A, Elmets CA, Koo J, et al. Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes. J Drugs Dermatol 2008; 7: 245-253.
86. Wolf P, Hofer A, Legat FJ, Bretterklieber A, Weger W, Salmhofer W, et al. Treatment with 311-nm ultraviolet B accelerates and improves the clearance of psoriatic lesions in patients treated with etanercept. Br J Dermatol 2009; 160: 186-189.
87. Kircik LH, Liu C, Goffe BS. Treatment of moderate to severe plaque psoriasis with concomitant efalizumab and narrow-band ultraviolet B phototherapy. J Drugs Dermatol 2008; 7: 947-952.
88. Carrascosa JM, Soria X, Ferrandiz C. Effective management of a psoriatic flare with narrowband UVB phototherapy during efalizumab therapy without discontinuing treatment. J Eur Acad Dermatol Venereol 2007; 21: 828-829. (Pubitemid 46939062)
89. Lucas A, Belinchon I, Perez-Crespo M, Mataix J, Betlloch I. Successful response to narrow-band UVB in a patient undergoing concomitant treatment with adalimumab for psoriasis. Australas J Dermatol 2008; 49: 173-174.
90. Yamauchi PS, Lowe NJ. Cessation of cyclosporine therapy by treatment with etanercept in patients with severe psoriasis. J Am Acad Dermatol 2006; 54: S135-S138.
91. Costanzo A, Talamonti M, Spallone G, Botti E, Chimenti MS, Papoutsaki M, et al. Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy. Dermatology 2009; 218: 146-150.
92. Owen CM, Harrison PV. Successful treatment of severe psoriasis with basiliximab, an interleukin-2 receptor monoclonal antibody. Clin Exp Dermatol 2000; 25: 195-197.
93. Hamilton TK. Treatment of psoriatic arthritis and recalcitrant skin disease with combination therapy. J Drugs Dermatol 2008; 7: 1089-1093.
94. Zargari O. Sustained effects of low dose infliximab in combination with methotrexate in the management of chronic recalcitrant psoriasis. Dermatol Online J 2005; 11: 21. (Pubitemid 43034797)
95. Krell JM. Use of alefacept and etanercept in 3 patients whose psoriasis failed to respond to etanercept. J Am Acad Dermatol 2006; 54: 1099-1101.
96. Gach JE, Berth-Jones J. Successful treatment of recalcitrant psoriasis with a combination of infliximab and hydroxyurea. J Dermatolog Treat 2003; 14: 226-228. (Pubitemid 37474534)
97. Gul U, Gonul M, Kilic A, Erdem R, Cakmak SK, Gunduz H. Treatment of psoriatic arthritis with etanercept, methotrexate, and cyclosporin A. Clin Ther 2006; 28: 251-254.
98. Reitamo S, Spuls P, Sassolas B, Lahfa M, Claudy A, Griffiths CE. Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial. Br J Dermatol 2001; 145: 438-445. (Pubitemid 32953701)
99. Sauer GC. Combined methotrexate and hydroxyurea therapy for psoriasis. Arch Dermatol 1973; 107: 369-370.
100. Balasubramaniam P, Stevenson O, Berth-Jones J. Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities. Br J Dermatol 2004; 150: 741-746. (Pubitemid 38586226)
101. Kohn D, Flatau E, Daher O, Zuckerman F. Treatment of psoriasis with daunorubicin and cytarabine. Arch Dermatol 1980; 116: 1101-1102.
102. Merk H, Goerz G, Runne U, Kurka M, Schafer J, Brendel E. Cimetidine and chlorpheniramine in the treatment of psoriasis. Dermatologica 1983; 166: 94-96.
103. Trivin F, Boucher E, Raoul JL. Complete sustained regression of extensive psoriasis with cetuximab combination chemotherapy. Acta Oncol 2004; 43: 592-593. (Pubitemid 39318561)
104. Stern RS, Liebman EJ, Vakeva L. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study. J Natl Cancer Inst 1998; 90: 1278-1284. (Pubitemid 28433472)
105. Nijsten TE, Stern RS. Oral retinoid use reduces cutaneous squamous cell carcinoma risk in patients with psoriasis treated with psoralen-UVA: a nested cohort study. J Am Acad Dermatol 2003; 49: 644-650.